White House Endorses 'Critical' FDA User Fee Legislation
The White House on Thursday threw its weight behind legislation reauthorizing and expanding user fees that fund U.S. Food and Drug Administration pharmaceutical reviews, labeling the bill "critical to the nation's...To view the full article, register now.
Already a subscriber? Click here to view full article